WebApr 18, 2024 · Mayleben stepped down as CEO of Esperion Therapeutics a little less than a year ago after a Q1 misfire on the numbers raised fresh doubts about the future of their cholesterol drug bempedoic acid ... WebApr 3, 2024 · Esperion Reports Third Quarter 2024 Financial Results and Provides Company Update
Esperion Therapeutics, Inc. (ESPR): Are Hedge Funds Right About …
WebApr 30, 2008 · Esperion Therapeutics, Inc. discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or … WebJan 5, 2024 · Meditor Group Ltd added to a holding in Esperion Therapeutics Inc by 58.53%. The purchase prices were between $4.81 and $11.73, with an estimated average price of $7.9. The stock is now traded at ... binary ethylenimine preparation
Esperion Announces $56.7 Million Registered Direct Offering
Web提供今日Esperion Therapeutics(ESPR)行情数据,包括价格,各周期走势图,基本资料及实时新闻资讯,财务分析,公司介绍,分红派息信息,您还可使用富途牛牛开户交易Esperion Therapeutics股票,为投资者提供参考决策数据。 WebGet the latest Esperion Therapeutics Inc (ESPR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebComplete Esperion Therapeutics Inc. stock information by Barron's. View real-time ESPR stock price and news, along with industry-best analysis. binary event stocks